| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Date Filed |
|---|---|---|---|---|---|---|---|---|
| Q3 2024 | 201 | $1.25B | +$231M | -$178M | +$52.3M | SPY, BAC, JPM, CSCO, CMC | 13F-HR | 11/1/2024, 11:12 AM |
| Q2 2024 | 197 | $1.14B | +$143M | -$287M | -$144M | SPY, BAC, JPM, CMC, EFC | 13F-HR | 7/25/2024, 04:16 PM |
| Q1 2024 | 203 | $1.31B | +$491M | -$206M | +$284M | SPY, JPM, CMC, EFC, BAC | 13F-HR | 5/3/2024, 03:30 PM |
| Q4 2023 | 190 | $934M | +$135M | -$185M | -$49.4M | JPM, CMC, CTRA, CNO, CSCO | 13F-HR | 2/14/2024, 02:25 PM |
| Q3 2023 | 182 | $908M | +$108M | -$304M | -$196M | CSCO, JPM, CMC, CTRA, VTRS | 13F-HR | 11/13/2023, 04:04 PM |
| Q2 2023 | 191 | $1.12B | +$117M | -$187M | -$69.6M | VTRS, CSCO, JPM, VZ, GS | 13F-HR | 11/13/2023, 04:01 PM |
| Q1 2023 | 187 | $1.13B | +$182M | -$196M | -$14.2M | CSCO, VTRS, D, VZ, GS | Restatement | 11/13/2023, 03:59 PM |
| Q4 2022 | 183 | $1.16B | +$179M | -$194M | -$15.2M | TFC, BIO, D, CSCO, VTRS | Restatement | 11/13/2023, 03:05 PM |
| Q3 2022 | 183 | $1.04B | +$117M | -$126M | -$9.52M | TFC, GS, D, MRK, PXD | 13F-HR | 11/9/2022, 09:04 AM |
| Q2 2022 | 183 | $1.12B | +$192M | -$229M | -$37.4M | GS, UL, TFC, PFE, D | 13F-HR | 8/10/2022, 09:46 AM |
| Q1 2022 | 182 | $1.32B | +$226M | -$278M | -$52.2M | CSCO, T, PFE, D, GS | 13F-HR | 5/13/2022, 05:16 PM |
| Q4 2021 | 187 | $1.37B | +$273M | -$444M | -$171M | CSCO, UL, GS, DD, VYX | Restatement | 8/2/2022, 09:46 AM |
| Q3 2021 | 274 | $1.48B | $0 | $0 | CSCO, MRK, DD, GS, BRKB | New Holdings | 11/15/2021, 05:40 PM | |
| Q3 2021 | 274 | $1.48B | +$768M | -$117M | +$651M | CSCO, MRK, DD, GS, BRKB | 13F-HR | 11/1/2021, 02:59 PM |
| Q2 2021 | 187 | $852M | +$163M | -$189M | -$25.8M | MRK, GM, DD, GS, C | Restatement | 7/27/2021, 11:19 AM |
| Q1 2021 | 182 | $835M | +$176M | -$167M | +$9.64M | GM, MRK, CNP, DD, IP | 13F-HR | 5/11/2021, 11:11 AM |
| Q4 2020 | 131 | $723M | +$137M | -$2.36B | -$2.22B | GM, PRMW, ADM, MS, ABBV | 13F-HR | 2/16/2021, 02:40 PM |
| Q3 2020 | 114 | $2.52B | +$697M | -$379M | +$319M | INTC, ABBV, DD, GM, BRKB | 13F-HR | 11/16/2020, 05:00 PM |
| Q2 2020 | 94 | $2.2B | +$485M | -$991M | -$506M | ABBV, INTC, ADM, BRKB, ETN | 13F-HR | 8/14/2020, 09:57 AM |
| Q1 2020 | 80 | $2.26B | +$472M | -$749M | -$277M | ABBV, THS, CNP, INTC, ADM | 13F-HR | 5/13/2020, 12:14 PM |
| Q4 2019 | 79 | $3.56B | +$463M | -$605M | -$143M | AIG, CNP, ABBV, GM, C | 13F-HR | 2/11/2020, 05:05 PM |
| Q3 2019 | 89 | $3.56B | +$730M | -$1.05B | -$322M | CNP, ABBV, AIG, INTC, GM | 13F-HR | 11/14/2019, 11:17 AM |
| Q2 2019 | 92 | $3.98B | +$911M | -$1.05B | -$139M | BIO, AIG, T, JPM, OXY | 13F-HR | 8/13/2019, 01:40 PM |
| Q1 2019 | 89 | $4.14B | $0 | $0 | DWDP, AIG, PFE, T, OXY | 13F-HR | 5/13/2019, 12:24 PM |